S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
The “Perfect Storm” for Gold (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
PayPal’s User Decline Won’t Stop Its Double-Digit Upside
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
The “Perfect Storm” for Gold (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
PayPal’s User Decline Won’t Stop Its Double-Digit Upside
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
The “Perfect Storm” for Gold (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
PayPal’s User Decline Won’t Stop Its Double-Digit Upside
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
The “Perfect Storm” for Gold (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
How to Know Which AI Company to Invest In… and When (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
PayPal’s User Decline Won’t Stop Its Double-Digit Upside
Free Trial
NASDAQ:VIVE

Viveve Medical (VIVE) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free VIVE Stock Alerts
$0.0002
0.00 (-33.33%)
(As of 01:46 PM ET)
Compare
Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.11
Volume
1,055 shs
Average Volume
3,503 shs
Market Capitalization
$2,144.80
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsSEC FilingsSocial Media
VIVE stock logo

About Viveve Medical Stock (NASDAQ:VIVE)

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

VIVE Stock Price History

VIVE Stock News Headlines

April 15, 2024 | finance.yahoo.com
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
February 23, 2024 | benzinga.com
Viveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, Predictions
April 16, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
July 29, 2023 | seekingalpha.com
VIVE Viveve Medical, Inc.
July 25, 2023 | finance.yahoo.com
InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents
June 14, 2023 | uk.finance.yahoo.com
VIVE - Viveve Medical, Inc.
February 24, 2023 | finance.yahoo.com
Viveve Medical, Inc. (VIVE)
January 17, 2023 | msn.com
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
January 17, 2023 | finanznachrichten.de
Viveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
January 17, 2023 | seekingalpha.com
Viveve crashes ~60% as company decides to delist, explore sale after trial fails
January 17, 2023 | finance.yahoo.com
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
January 17, 2023 | finance.yahoo.com
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
January 17, 2023 | investorplace.com
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
December 29, 2022 | insidermonkey.com
Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript
December 15, 2022 | finance.yahoo.com
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
December 1, 2022 | finanznachrichten.de
Viveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
December 1, 2022 | finance.yahoo.com
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
November 13, 2022 | finance.yahoo.com
Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
November 10, 2022 | finanznachrichten.de
Viveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022 | finance.yahoo.com
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 27, 2022 | finance.yahoo.com
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
October 25, 2022 | finance.yahoo.com
Global Cosmetic Gynecology Market Report to 2027 - Featuring Alma Laser, Lutronic, Viveve Medical and Venus Concept Among Others
October 13, 2022 | forbes.com
Viveve Medical
October 4, 2022 | finanznachrichten.de
Viveve Medical, Inc.: Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
October 4, 2022 | finance.yahoo.com
Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
September 27, 2022 | finance.yahoo.com
Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout
See More Headlines
Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/16/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VIVE
Previous Symbol
OTCMKTS:PLCSD
CUSIP
N/A
CIK
879682
Web
www.viveve.com
Phone
(720) 696-8100
Fax
720-696-8199
Employees
47
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$6.83 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,724,000
Free Float
10,110,000
Market Cap
$2,144.80
Optionable
Not Optionable
Beta
0.08
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Jim B. Robbins (Age 60)
    Senior VP of Finance & Administration and Principal Accounting & Financial Officer
    Comp: $386.94k
  • Ms. Deborah Ann Jorn M.B.A. (Age 66)
    Senior Advisor to the CEO & Director
    Comp: $35k
  • Mr. Martin Kerber P.E.
    Vice President of Research, Development & Operations
  • Ms. Jeannie Swindle
    Senior Director of Corporate Communications
  • Mr. Jeff Sinclair
    Vice President of International Sales
  • Mr. Gary Kaiser
    Vice President of Global Marketing
  • Ms. Lori McMillan
    Vice President of Human Resources
  • Ms. Suzon D. Lommel (Age 66)
    Senior Vice President of Regulatory & Quality Affairs

Key Competitors

View All Competitors

VIVE Stock Analysis - Frequently Asked Questions

How have VIVE shares performed in 2024?

Viveve Medical's stock was trading at $0.0002 on January 1st, 2024. Since then, VIVE shares have increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) released its earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $0.09. The business earned $1.62 million during the quarter. During the same quarter in the prior year, the firm posted ($2.60) EPS.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?

Viveve Medical (VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VIVE) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
You won't believe what Citigroup just did to it's depositors
American Alternative
Options trading has suddenly become more reliable.
Eagle Publishing